| P2093 | author name string | David M Nanus | |
| | Maha Hussain | |
| | Matthew I Milowsky | |
| | Oscar B Goodman | |
| | Jodi Kaplan | |
| P2860 | cites work | New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada | Q27860904 |
| | Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study | Q28139358 |
| | The complexity of targeting EGFR signalling in cancer: from expression to turnover | Q36556837 |
| | erbB receptor expression patterns in human bladder cancer | Q39722178 |
| | HER-2/neu signal transduction in human breast and ovarian cancer | Q41328221 |
| | Targeting gene transcription: a new strategy to down-regulate c-erbB-2 expression in mammary carcinoma | Q41354221 |
| | Plasma and cerebrospinal fluid pharmacokinetics of gemcitabine after intravenous administration in nonhuman primates | Q43629737 |
| | HER2/neu gene amplification and protein overexpression in G3 pT2 transitional cell carcinoma of the bladder: a role for anti-HER2 therapy? | Q44700955 |
| | Carcinomatous meningitis from urothelial carcinoma of bladder and ureter: case report | Q45205710 |
| | Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer | Q46610841 |
| | HER-2/neu protein overexpression and gene amplification in human transitional cell carcinoma of the bladder | Q47794879 |
| | Meningeal carcinomatosis from transitional cell carcinoma of the bladder | Q48249090 |
| | HER2 in brain metastases: issues of concordance, survival, and treatment. | Q48479849 |
| | Cerebrospinal fluid pharmacokinetics of carboplatin in children with brain tumors | Q48563308 |
| | Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder. | Q52059159 |
| | Phase I and pharmacodynamic study of taxol in refractory acute leukemias. | Q54389823 |
| | [A case of carcinomatous meningitis from transitional cell carcinoma of the urinary bladder] | Q72564183 |
| | Trastuzumab in CSF | Q73829301 |
| | Her-2/neu overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic significance and comparative analysis in primary and metastatic tumors | Q74321060 |
| | HER2 overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic implications | Q78516471 |
| | Trastuzumab, paclitaxel, carboplatin, and gemcitabine in advanced human epidermal growth factor receptor-2/neu-positive urothelial carcinoma: results of a multicenter phase II National Cancer Institute trial | Q80406288 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meningitis | Q48143 |
| | trastuzumab | Q412616 |
| | bladder cancer | Q504775 |
| | chemotherapy | Q974135 |
| P304 | page(s) | 9110 | |
| P577 | publication date | 2009-09-15 | |
| P1433 | published in | Journal of Medical Case Reports | Q6295519 |
| P1476 | title | Carcinomatous meningitis in a patient with Her2/neu expressing bladder cancer following trastuzumab and chemotherapy: a case report and review of the literature | |
| P478 | volume | 3 | |